Syndrome News and Research

RSS

Prior SARS-CoV-2 infection provides substantial and sustained protection from Omicron hospitalization

A population-level study conducted on residents of the Quebec province, Canada, has demonstrated that prior infection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) induces robust and long-lasting protection against omicron re-infection and hospitalization. The level of protection further increases with coronavirus disease 2019 (COVID-19) vaccination.

3 May 2022

Understanding how the COVID pandemic impacts childhood autism and neurodevelopmental disorders

A study posted to the medRxiv* preprint server assessed the effects and outcomes of the COVID-19 pandemic on children suffering from neurodevelopmental disorders, with an emphasis on patients of autism spectrum disorder (ASD).

3 May 2022

Schools' role in the spread of SARS-CoV-2

The Omicron wave of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)––the causative pathogen for coronavirus disease 2019 (COVID-19) and the current pandemic––led to rampant transmissions in schools. Therefore, the school-based viral transmission must be curtailed to reduce viral evolution and maintain children's in-person education.

2 May 2022

Study uses brain organoids to reveal how autism-linked genetic mutation disrupts neural development

In a study published May 02, 2022 in Nature Communications, scientists at University of California San Diego School of Medicine used human brain organoids to reveal how a genetic mutation associated with a profound form of autism disrupts neural development.

2 May 2022

Tracking BA.2.12.1 🦠 by partial ORF1ab gene 🧬 target failure (pOGTF)

Scientists from the United States have recently identified a novel approach to rapidly and accurately detect the omicron BA.2.12.1 sub-lineage of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in clinical samples.

2 May 2022

P681 mutations in SARS-CoV-2 spike protein determine fusogenicity

Researchers evaluated the importance of the P681 residue within the furin cleavage site of SARS-CoV-2 spike protein in determining the fusogenicity and syncytia formation ability of SARS-CoV-2 strains.

2 May 2022

Exploring changes in non-COVID-19 hospitalization rates before and during COVID-19

Researchers assessed the trends in non-COVID-19 hospitalizations before and during the COVID-19 pandemic in the United States between 2017 and 2021.

2 May 2022

Estimating COVID-19 case prevalence in New York City

Researchers estimated the prevalence of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) in New York City (NYC).

2 May 2022

Prevalence of low-molecular-weight heparin prescription in pregnant women according to level of venous thromboembolic disease risk

The present study was carried out to determine how often LMWH was prescribed in pregnancy, the risk classification of such women based on the ETV-OBS risk calculator, and how the risk varied with the occurrence of SARS-CoV-2 infection.

2 May 2022

Fourth dose of COVID-19 vaccine reduced death among hospitalized patients during Omicron wave in Israel

Researchers investigated the effect of a fourth dose of the coronavirus disease 2019 (COVID-19) vaccine in patients with severe disease symptoms.

2 May 2022

Study estimates the elevated risks of COVID-19 breakthrough infection and hospitalization in fully vaccinated individuals with comorbidities

The current study aimed to understand both the risk of breakthrough infection and severe outcomes in this population.

2 May 2022

Higher contact among vaccinated people may negatively influence vaccine effectiveness

In a new study, researchers reported that contact among vaccinated people could influence the effectiveness of COVID-19 vaccines.

2 May 2022

Neutralizing antibodies produced following COVID-19 BNT162b2 vaccine found to activate complement cascade

Researchers investigated the complement component 1q (C1q) binding and subsequent complement activation by neutralizing antibodies (nAbs) produced following COVID-19 vaccination.

2 May 2022

The generation of SARS-CoV-2 virus-like particles in insect cells

Researchers have reported the development of a promising COVID-19 vaccine candidate which is based on SARS-CoV-2 VLPs, derived from the co-expression of the spike, membrane, and envelope structural proteins in the baculovirus expression system.

2 May 2022

Higher vaccination coverage associated with lower rates of population-level COVID-19 mortality and incidence in the US

By using data representing 80% of the US population, researchers have found that increased vaccination coverage against COVID-19 can be linked to a reduced incidence of cases and deaths.

2 May 2022

SARS-CoV-2-specific T cells are broader after vaccination than after infection

In a recent study published in the Nature Microbiology journal, researchers investigated the characteristics of coronavirus disease 2019 (COVID-19) infection in convalescent and vaccinated individuals.

1 May 2022

Study finds 67% of individuals with long COVID are developing dysautonomia

In a recent study posted to the medRxiv* preprint server, researchers analyzed the traits of autonomic symptom burden in long coronavirus disease (COVID).

1 May 2022

SARS-CoV-2 viral shedding varies widely in asymptomatic and mildly ill patients

In a recent study published in the Nature Microbiology journal, researchers assessed the longitudinal viral dynamics in asymptomatic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections.

1 May 2022

$Can fractional doses of COVID-19 vaccines protect against SARS-CoV-2?$

Can fractional doses of COVID-19 vaccines protect against SARS-CoV-2?

A recent research paper posted to the Research Square* preprint server assessed the dose fractionation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines.

1 May 2022

Antibody cocktail shows synergetic effects against SARS-CoV-2 Omicron in vitro and in vivo

A recent research paper posted to the bioRxiv* preprint server demonstrated that a cocktail of two synergetic antibodies extensively neutralized severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants, including Omicron BA.1 and BA.2.

1 May 2022

Syndrome News and Research

Prior SARS-CoV-2 infection provides substantial and sustained protection from Omicron hospitalization

Understanding how the COVID pandemic impacts childhood autism and neurodevelopmental disorders

Schools' role in the spread of SARS-CoV-2

Study uses brain organoids to reveal how autism-linked genetic mutation disrupts neural development

Tracking BA.2.12.1 🦠 by partial ORF1ab gene 🧬 target failure (pOGTF)

P681 mutations in SARS-CoV-2 spike protein determine fusogenicity

Exploring changes in non-COVID-19 hospitalization rates before and during COVID-19

Estimating COVID-19 case prevalence in New York City

Prevalence of low-molecular-weight heparin prescription in pregnant women according to level of venous thromboembolic disease risk

Fourth dose of COVID-19 vaccine reduced death among hospitalized patients during Omicron wave in Israel

Study estimates the elevated risks of COVID-19 breakthrough infection and hospitalization in fully vaccinated individuals with comorbidities

Higher contact among vaccinated people may negatively influence vaccine effectiveness

Neutralizing antibodies produced following COVID-19 BNT162b2 vaccine found to activate complement cascade

The generation of SARS-CoV-2 virus-like particles in insect cells

Higher vaccination coverage associated with lower rates of population-level COVID-19 mortality and incidence in the US

SARS-CoV-2-specific T cells are broader after vaccination than after infection

Study finds 67% of individuals with long COVID are developing dysautonomia

SARS-CoV-2 viral shedding varies widely in asymptomatic and mildly ill patients

Can fractional doses of COVID-19 vaccines protect against SARS-CoV-2?

Antibody cocktail shows synergetic effects against SARS-CoV-2 Omicron in vitro and in vivo

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News